Are survival rates for Tyrol published in the Eurocare studies biased?

References

• Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, et al. EUROCARE-3: Survival of cancer patients diagnosed 1990–94–results and commentary. Ann Oncol 2003; 14(Suppl 5)61–118
   PubMed Web of Science ®Google Scholar
• Berrino F, Angelis R, Sant M, Rosso S, Bielska Lasota M, Coebergh JW, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: Results of the EUROCARE-4 study. Lancet Oncol 2007; 8: 773–83
   PubMed Web of Science ®Google Scholar
• Verdecchia V, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, et al. Recent cancer survival in Europe: A 2000–02 period analysis of EUROCARE-4 data. Lancet Oncol 2007; 8: 784–96
   PubMed Web of Science ®Google Scholar
• Bray, F, Parkin, DM. Evaluation of data quality in the cancer registry: Principles and methods. Part I: Comparability, validity and timeliness. Eur J Cancer. 2008, doi:10.1016/j.ejca.2008.11.032.
   Google Scholar
• Parkin, DM, Bray, F. Evaluation of data quality in the cancer registry: Principles and methods. Part II: Completeness. Eur J Cancer. 2009, doi:10.1016/j.ejca.2008.11.0334.
   Google Scholar
• Brenner H, Hakulinen T. Reduction in selective under-ascertainment bias in population-based estimates of cancer patient survival by age adjustment. Eur J Cancer 2005; 41: 1788–93
   PubMed Web of Science ®Google Scholar
• Brenner H, Hakulinen T. Population-based monitoring of cancer patient survival in situations with imperfect completeness of cancer registration. Br J Cancer 2005; 92: 576–9
   PubMed Web of Science ®Google Scholar
• Quinn MJ, Wood H, Cooper N. Cancer atlas of the United Kingdom and Ireland 1991–2000. Office for National Statistics (ONS), London 2005
   Google Scholar
• ENCR[Internet]. Empfehlungen zur Verschlüsselung des Diagnosezeitunktes. [cited 2. Feb 2009]. Available from:URL: http://www.encr.com.fr/incidger.pdf.
   Google Scholar
• DM Parkin, Whelan, SL, Ferlay, J, Raymond, L, Young, J. Cancer incidence in five continents, VII. IARC Scientific Publications No. 143. Lyon: IARC; 1997.
   Google Scholar
• DM Parkin, Whelan, SL, Ferlay, J, Teppo, L, Thomas, B. Cancer incidence in five continents, VIII. IARC Scientific Publications No. 155. Lyon: IARC; 2002.
   Google Scholar
• MP Curado, Edwards, B, Shin, HR, Storm, H, Ferlay, J, Heanue, M, , et al, Cancer incidence in five continents. Vol. IX, , IARC Scientific Publications No. 160. Lyon: IARC; 2007.
   Google Scholar
• OM Jensen, Parkin, DM, MacLennan, R, Muir, CS, Skeet, RG, Cancer registration principles and methods. Lyon: IARC-Press; 1991.
   Google Scholar
• Leitner B. Qualitätsaspekte der Todesursachenstatistik. Statist Nachrichten 2005; 9: 790–7
   Google Scholar
• Oberaigner W, Stühlinger W. Record linkage in the cancer registry of Tyrol. Methods Inf Med 2005; 44: 626–30
   PubMedGoogle Scholar
• Bullard J, Coleman MP, Lutz JM, Bell J, Peto J. Completeness of cancer registration: new method for routine use. Br J Cancer 2000; 82: 111–6
   Google Scholar
• Silcocks PBS, Robinson D. Completeness of ascertainment by cancer registries: Putting bounds on the number of missing cases. J Public Health 2004; 26: 161–7
   Web of Science ®Google Scholar
• Dickman PW[Internet]. strs Version 1.2.8. [cited 21. June 2007]. Available from: http://www.pauldickman.com/rsmodel/.
   Google Scholar
• Stata Statistical Software: Release 9.0. College Station, Tx: StataCorp LP. 2005.
   Google Scholar
• Larsen, IK, Smastuen, M, Johannesen, TB, Langmark, F, Parkin, DM, Bray, F, , et al. Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness. Eur J Cancer. 2008, doi:10.1016/j.ejca.2008.10.037.
   Google Scholar
• Bartsch G, Horninger W, Klocker H, Reissigl A, Oberaigner W, Schonitzer D, et al. Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the federal state of Tyrol, Austria. Urology 2001; 58: 417–24
   PubMed Web of Science ®Google Scholar
• Oberaigner W, Horninger W, Klocker H, Schonitzer D, Stuhlinger W, Bartsch G. Reduction of prostate cancer mortality in Tyrol, Austria, after introduction of prostate-specific antigen testing. Am J Epidemiol 2006; 164: 376–84
   PubMedGoogle Scholar
• Bartsch G, Horninger W, Klocker H, Pelzer A, Bektic J, Oberaigner W, et al. Tyrol Prostate Cancer Demonstration Project: Early detection, treatment, outcome, incidence and mortality. BJU Int 2008; 101: 809–16
   PubMed Web of Science ®Google Scholar
• Du Bois A, Rochon J, Lamparter C, Pfisterer J. Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer. Int J Gynecol Cancer 2005; 15: 183–91
   PubMed Web of Science ®Google Scholar
• Oberaigner W. Errors in survival rates caused by routinely used deterministic record linkage methods. Methods Inf Med 2007; 46: 420–4
   PubMed Web of Science ®Google Scholar
• Hall S, Schulze K, Groome P, Mackillop W, Holowaty E. Using cancer registry data for survival studies: The example of the Ontario Cancer Registry. J Clin Epid 2006; 59: 67–76
   PubMed Web of Science ®Google Scholar